[HTML][HTML] Crystal structures of human ETB receptor provide mechanistic insight into receptor activation and partial activation

W Shihoya, T Izume, A Inoue, K Yamashita… - Nature …, 2018 - nature.com
W Shihoya, T Izume, A Inoue, K Yamashita, FMN Kadji, K Hirata, J Aoki, T Nishizawa…
Nature communications, 2018nature.com
Endothelin receptors (ETA and ETB) are class A GPCRs activated by vasoactive peptide
endothelins, and are involved in blood pressure regulation. ETB-selective signalling induces
vasorelaxation, and thus selective ETB agonists are expected to be utilized for improved anti-
tumour drug delivery and neuroprotection. Here, we report the crystal structures of human
ETB receptor in complex with ETB-selective agonist, endothelin-3 and an ETB-selective
endothelin analogue IRL1620. The structure of the endothelin-3-bound receptor reveals that …
Abstract
Endothelin receptors (ETA and ETB) are class A GPCRs activated by vasoactive peptide endothelins, and are involved in blood pressure regulation. ETB-selective signalling induces vasorelaxation, and thus selective ETB agonists are expected to be utilized for improved anti-tumour drug delivery and neuroprotection. Here, we report the crystal structures of human ETB receptor in complex with ETB-selective agonist, endothelin-3 and an ETB-selective endothelin analogue IRL1620. The structure of the endothelin-3-bound receptor reveals that the disruption of water-mediated interactions between W6.48 and D2.50 is critical for receptor activation, while these hydrogen-bonding interactions are partially preserved in the IRL1620-bound structure. Consistently, functional analysis reveals the partial agonistic effect of IRL1620. The current findings clarify the detailed molecular mechanism for the coupling between the orthosteric pocket and the G-protein binding, and the partial agonistic effect of IRL1620, thus paving the way for the design of improved agonistic drugs targeting ETB.
nature.com